Pleiotrophin/PTN Antibody (851406) Summary
Immunogen |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Pleiotrophin/PTN Gly33-Asp168 Accession # P21246 |
Specificity |
Detects human Pleiotrophin/PTN in ELISAs.
In direct ELISAs, no cross-reactivity
with recombinant mouse Pleiotrophin/PTN or recombinant human Midkine is
observed. |
Source |
N/A |
Isotype |
IgG2b |
Clonality |
Monoclonal |
Host |
Rat |
Gene |
PTN |
Purity Statement |
Protein A or G purified from hybridoma culture supernatant |
Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
Dilutions |
- Immunocytochemistry 8-25 ug/mL
|
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS. |
Preservative |
No Preservative |
Concentration |
LYOPH |
Reconstitution Instructions |
Sterile PBS to a final concentration of 0.5 mg/mL. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Pleiotrophin/PTN Antibody (851406)
Background
Pleiotrophin (PTN), also called heparin-binding growth-associated molecule (HB-GAM), heparin-binding neurotrophic factor (HBNF), heparin-affinity regulatory peptide (HARP), or osteoblast-specific factor (OSF-1), is an 18 kDa secreted, strongly heparin-binding, developmentally regulated cytokine (1 ‑ 3). PTN and Midkine share 50% amino acid (aa) sequence identity, share some functions, and constitute a family (1 ‑ 3). The second of two TSP1 domains contains the highest affinity binding site for heparin (4, 5). A 15 kDa form which lacks the C-terminus is mitogenic for glioblastoma cells, while full-length PTN is not (6). PTN is a highly conserved protein; human, mouse, rat, canine, porcine, equine and bovine PTN share 98% aa sequence identity or greater. During development, PTN is involved in development of brain, bone, and organs undergoing branching morphogenesis (3). In the adult, it is induced by PDGF and upregulated in many cancers, hematopoietic stem cells and tissues undergoing remodeling (7 ‑ 10). Cell surface receptors for PTN include Syndecan-3 (which mediates neurite outgrowth) and the receptor tyrosine phosphatase PTPRB, also called RPTP beta / zeta (3, 11 ‑ 13). Heparin binding is necessary for engaging these receptors (7, 8). PTN causes PTPRB dimerization and inactivates its phosphatase activity, which allows increased tyrosine phosphorylation of its substrates (12 ‑ 14). One such substrate is the WNT pathway molecule beta -catenin, allowing crosstalk of PTN with WNTs (12). PTN activation of the receptor ALK (anaplastic lymphoma kinase) is indirect through PTPRB, and mediates mitogenic, transforming and angiogenic activities of PTN (2, 5, 6, 13). Increased expression of PTN is correlated with neuronal development or stresses such as brain ischemia and Parkinson’s disease (2, 3, 7, 8). Both PTN and Midkine have demonstrated bactericidal activity, but only in the absence of heparin (15).
References
- Naito, A. et al. (1992) Biochem. Biophys. Res. Commun. 183:701.
- Perez-Pinera, P. et al. (2008) Curr. Opin. Hematol. 15:210.
- Weng, T. and L. Liu (2010) Respir. Res. 11:80.
- Raulo, E. et al. (2005) J. Biol. Chem. 280:41576.
- Hamma-Kourbali, Y. et al. (2008) J. Cell. Physiol. 214:250.
- Lu, K.V. et al. (2005) J. Biol. Chem. 280:16953.
- Yeh, H-J. et al. (1998) J. Neurosci. 18:3699.
- Marchionini, D.M. et al. (2007) Brain Res. 1147:77.
- Chang, Y. et al. (2007) Proc. Natl. Acad. Sci. USA 104:10888.
- Himburg, H.A. et al. (2010) Nat. Med. 16:475.
- Kinnunen, T. et al. (1996) J. Biol. Chem. 271:2243.
- Meng, K. et al. (2000) Proc. Natl. Acad. Sci. USA 97:2603.
- Perez-Pinera, P. et al. (2007) J. Biol. Chem. 282:28683.
- Fukada, M. et al. (2006) FEBS Lett. 580:4051.
- Svensson, S.L. et al. (2010) J. Biol. Chem. 285:16105.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: ELISA, IHC, IHC-P, S-ELISA, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, IP, WB
Species: Hu
Applications: WB
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA
Species: Hu
Applications: IHC, Simple Western, WB
Species: Hu
Applications: WB
Species: Hu
Applications: CyTOF-ready, Flow, ICC, WB
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: BA
Species: Hu
Applications: IHC, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: IHC, Neut, Simple Western, WB
Species: Hu
Applications: IP, WB
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
Publications for Pleiotrophin/PTN Antibody (MAB252) (0)
There are no publications for Pleiotrophin/PTN Antibody (MAB252).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Pleiotrophin/PTN Antibody (MAB252) (0)
There are no reviews for Pleiotrophin/PTN Antibody (MAB252).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for Pleiotrophin/PTN Antibody (MAB252) (0)
Secondary Antibodies
| |
Isotype Controls
|
Additional Pleiotrophin/PTN Products
Blogs on Pleiotrophin/PTN